Introduction
The open surgical wounds heal mainly for two basic mechanisms: contraction of the borders of the wounds and migration of epithelial cells. The contraction reduces the size of the total thickness of the operative wound through centripetal movements of the skin surrounding tissues. Afterwards the capillaries of the wound margins form new vassels, migration of fibroblasts happens and the wound will be fill out 1, 2, 3 . The contraction of the open wounds depends on the capacity of the fibroblastos to contract and move through the extracelular matrix. The wounds contraction is influenced by many factors, such as: steroids use, diabetes, avitaminosis and infection. The infection is one of the main factors that alter the physiologic evolution of the wound healing 4, 5, 6 . The bacteria can affect the contraction of the wounds by many mechanisms. Perry and Sutkin et al demonstrated that the bacteria secrete exogen plasminogen activators, and produce proteolitic enzymes that may affect the extracelular matrix, blocking the wound contraction 8 . The bacteria are capable to inhibit the angiogenesis, reducing the two mechanisms of wound contraction 9 . It has been demonstrated that the basic fibroblast growth factor (FGFß) it is capable to revert the effects of the infection on the contraction in open wounds in all of the phases of the healing, through the fibroblasts formation and migration. In spite of reducing the time of healing, some studies demonstrated reduction in wounds strenght. FGFß has been able to improve the healing of incisional and open infected wounds by reducing its healing time, and increasing the DNA synthesis in extracellular matrix, without increasing the tensil strenght 7, 10 . Broadley et al demonstrated that the neutralization of FGFß for a specific anti-body is capable to revert their functions, causing a significant reduction of DNA, proteins and collagen synthesis, affecting the cytokines function 11 . In experiments with topical application of FGFß a significant inhibition of the open wounds contraction was observed 12, 13 . Medeiros et al, as well as McGee et al, observed that topical application of FGFß in incisional wounds increased significantly the density of collagen and the tensil strength in rats o submitted to infection, steroids use, radiotherapy and imunossupressors 14, 15 . Several studies have demonstrated that FGFß acts in the extracellular matrix stimulating angiogenesis, fibroblast migration, angiogenesis and fibrogenesis, enhancing the tensil strength and reducing the time for infected wounds scaring 3, 4, 5, 6, 7, 8, 9, 10 . So, the purpose of the present work was to study the topical effect of FGFß and its anti-factor on infected skin wounds of rats. We evaluated the expression of types I and III collagen, as well as its maturation, the time for wound scaring and the inflammatory reaction in the involved tissues.
Methods
Sixty Wistar rats weighing 270±23g were used. Animals were provided by the Nucleus of Experimental Surgery of the Federal University of Rio Grande do Norte, Brazil, with the approval of Ethics Committee in Research (Animal Care). The International guidelines for the care and use of laboratory animals were followed throughout the study. The animais were acclimatized to the research laboratory for 7 days before we started the experiments. Rats were housed under controlled illumination (12/12 hours light/dark cycle), humidity (60-70%), and temperature (22°C). The animals were randomly separated in groups and subgroups ( Figure 1 ) and observed in individual cages receiving water and food (LabinaPurina®) ad libitum. After 12 hours of fasting, the rats were anesthetized by intramuscular injection of 30mg/Kg of ketamine and 0,5mg/Kg of xylazine. Afterwards, dorsal skin depilation and anti-sepsis with 1% povidone were performed. The surgical procedures were performed under aseptic conditions. Two open squared wounds (1cm 2 ), 4cm distant to each other, were done in the dorsal skin of all the rats. These wounds were named W1 (for inflammation analysis) and W2 (for collagen study).
Treatment of wounds
In group A (n=30), immediately after the surgical procedure, the wounds were contaminated with the topical application (figure 2) of multibacterial standard solution (0,1ml of 1g of rats fresh feces and 1ml of saline). In the following day, the infected wounds of the subgroup A1 (n=10) were topically treated with 1 ml of saline solution. The sub-group A2 (n=10) rats wounds were treated with an unique dosis of FGF-ß 10ng diluted in 10ìl of saline (Sigma, USA). In sub-group A3 (n=10) rats, the wounds were topically treated with 10ng of FGF-ß + anti-FGF-ß (figure 3). In group B (n=30) rats, the wounds were not contaminated and the same topical treatments were accomplished as described to A.
Histological analysis
In the eighth postoperative day the W1 wound was ressected and fixed in formaline 10% by 3 days. The biopsies were processed following the routine and stained with hematoxilin and eosin (HE) for histological analysis of the inflammatory reaction. The rats were observed until complete epithelialization of W2 wounds for determination of healing time. Under anesthesia, the wounds were ressected and prepared to measure the expression of types I and III collagen, using Picro Sirius Red (Direct Red 80 from Aldrich Chemical Co, USA) staining and polarized filters. The type I collagen was identified by its thick fibers and compact and dense fibrils, yellow to light red colored. The type III collagen formed green fine fibers with thin fibrils 24 . The variables were analysed by the optical microscope Olympus B-50 and the quantification of cells, fibers and elements of the inflammatory reaction was performed by the Image Pro-Plus Média Cybernetics software, LP, USA. The statistical analysis was performed by ANOVA, t and Tukey tests, considering p<0.05 as significant.
Results

Time for healing
The healing time of W2 infected wounds of subgroup A1 was 21,5 days; in the subgroup A2, 12,87days, and 20,87 days in the subgroup A3. In the non-infected wounds of subgroup B1 the healing time was 9,70 days, in the subgroup B2 13,50 days, and in the subgroup B3 15,40 days (Table 1) . In infected wounds no treated with FGFb (subgroup A1) the healing time was comparable to the A3 rats, whose infected wounds were treated with FGFb and anti-FGFb (p>0.05). When the infected wounds were treated with FGFb (subgroup A2) we observed a significant reduction in the healing time, when compared with A1 subgroup (p<0.05). The same phenomenon was observed comparing the subgroups B1 and B2, meaning that FGFb remarkably contributed to accelerate the healing. The association of anti-FGFb in infected and no infected wounds, inhibited the beneficial effect of FGFb, as can be observed comparing subgroups A2-A3 and B2-B3 (Table 1) .
Histology
The density of inflammatory cells in the subgroup A3, whose infected wounds were treated with FGFb and antiFGFb, was shorter than that observed in all the other subgroups. The difference was significant when compared the subgroup A3 to A2 and B2 (p<0.05). In the wounds treated with FCFb, with and without infection (subgroups A2, B2), the density of fibroblasts contributed to a great density of inflammatory cells. (Table 2 ). The figures 4, 5 and 6 show histopathological details observed in the laminas of their respective subgroups. 
Qualitative and e quantitative analysis of type I colllagen
The density of type I collagen of subgroup B2 rats (treated with FGFb) was significantly higher (p<0.05) than in subgroup B1, using multiple comparisons by the Tukey test ( Table 2 ). The figure 7 displays high density of collagen type I in histological preparation of no infected wound of subgroup B2, that can be compared with the low density observed in the figure 8 (subgroup A1) . When the antiFGFb was used in the wounds (subgroups A3, B3), the density of the type I collagen had a significant reduction. In the infected wounds, the treatment with FGFb (subgroup A2) contributed to increase the density of the type I collagen, comparing to the control (subgroup A1). However, the differences in the density among those subgroups were not significant (p>0,05).
Analysis of type III collagen
Analyzing the expression of the type III collagen, it was observed that FGFb didn't stimulate its production in infected and no infected wounds, when compared with the controls (p>0.05). The treatment of wounds with anti-FCFß reduced significantly the density of type III collagen when those subgroups were compared with the wounds (A2, B2) treated with FCFß (p<0.05). The expression of the collagen type I was always significantly greater than the observed in type III collagen of all the other subgroups ( Table 2 ). The figure 9 demonstrates the low density of type III collagen in infected wound of the subgroup B3, where rare green fibers are seen. In figures 10 (subgroup A1), 11 (of the subgroup A3) and 12 (subgroup B2), a high density of the type III collagen is observed. 
Discussion
Injury to the skin initiates a cascade of events including inflammation, new tissue formation, and tissue remodeling, which finally lead to reconstruction of the wounded area 16, 17 . The repair process is initiated immediately after injury by the release of various growth factors, cytokines, and low-molecular weight compounds from the serum of injured blood vessels and from degranulating platelets. Disruption of blood vessels also leads to the formation of the blood clot, which is composed of cross-linked fibrin, and of extracellular matrix proteins such as fibronectin, tenascin, and thrombospondin 16, 17, 18 . The healing is an important phenomenon of the surgical treatment, and involves resistance of the sutured tissues, esthetics and recovery of function. In the management of skin wounds these aspects are essencial 1, 2, 3, 4 . The experimental surgical model used in this work allowed the analysis of the effects of FGFb on inflammation and on expression of types I and III collagen using the histochemical method with picrosirius red staining, exposed to polarized light 25, 26 . Multiple studies have demonstrated a beneficial effect of many growth factors, e.g., platelet-derived growth factors (PDGFs), fibroblast growth factors (FGFs), and granulocyte-macrophage colony stimulating factor (GM-CSF) on the healing process, both in animal models and also in patients suffering from different types of wound healing disorders and infection 27, 28, 29, 30, 31 . Using an only dosis of 10µg/ml, they observed a reduction in the healing time. In the same way, Hayward et al revealed that chronic burns benefit with the topical application of FGFb (100µg/ ml) 7 . The results of the present work revealed that the infection affects the healing time delaying the scaring of the open wounds, as seen in infected ones with no topical treatment with FGFb, where the mean healing time was of 21,5 days. When the infected wounds were topically treated with FGFb, the mean healing time was 12,8 days.
The exact biological mechanisms involving FGFs is controversial. The roles of endogenous growth factors in the healing response have been only partially elucidated. However, in vivo functions of many growth factors remain largely unconfirmed. The FGFs have a broad mitogenic spectrum. They stimulate proliferation of various cells of mesodermal, ectodermal, and also endodermal origin. In addition to their mitogenic effects, FGFs also regulate migration and differentiation of their target cells, and FGFs have been shown to be cytoprotective and to support cell survival under stress conditions 32, 33 . Numerous in vivo effects of FGFs have been demonstrated, which suggest a role of these growth factors in wound repair. In particular, FGFb was shown to stimulate angiogenesis in various assay systems 34 . Furthermore, FGFs are mitogenic for several cell types present at the wound site, including fibroblasts and keratinocytes 27 . Thus FGFs are clear candidates for contributing to the wound healing response, and this hypothesis has been corroborated by a number of studies where their local application stimulated tissue repair 35 . Mcgee et al and Slavin et al observed acceleration of wound healing time in diabetic rats, in chorticosteroid use and in infected wounds with an isolated topical application of FGFß. They observed increase in angiogenesis, fibroblasts proliferation and great deposition of collagen, comparing with controls 15, 23 . In clinical studies, it was made the topical use of FGFß in chronic peptic ulcers, in decubitus ulcers and in ocular lesions. The authors observed reduction in healing time and significant deposition of collagen in wounds 21, 24 . Medeiros et al observed that the topical application of a single dose FGFß in sutured skin wounds of rats stimulated the lymphocytes and fibroblasts proliferation, increased the collagen synthesis and tensil strength of wounds 14 . However, Stenberg et al, using a similar experimental design of the present work, demonstrated that FGFß enhances infected wounds, but does not increase tensil strength 10 . The collagen fibers are important components of the extracelular matrix, responsible for the tensil resistance of the wounds 3, 5, 12 . The role of FGF in wound repair was finally clarified when FGF null mice were used for wound healing studies. When they were challenged by full-thickness excisional wounding, they showed delayed healing 35 . In addition to a retardation in the rate of reepithelialization, mice null for FGF2 showed reduced collagen deposition at the wound site, and they had thicker scabs 35 . The tensil strength of operative wounds depends on some factors, such as the collagen level and the thickness and organization of their fibers 1 . It was demonstrated in the present work that the topical application of FGFß stimulated the deposition of types I and III collagen as observed in other studies 14, 15 . The concomitant use of FGFß and anti-FGFß antibody in open infected and clean wounds inhibited the collagen synthesis. To provide functional evidence for a role of FGF in wound repair, Broadley et al 11 used a neutralizing polyclonal antibody that was raised against human FGF. They incorporated the purified IgG into sponge disk, and the disks were then implanted subcutaneously under ventral panniculus carnosus of rats. The continuous release of the antibody caused a striking reduction in cellularity and vascularization compared with the granulation tissue formed in the control IgG sponges. In addition, DNA, protein, and collagen levels in the anti-FGF sponges were reduced by 25-35% relative to control at day 7 after implantation. This study strongly suggested an important role of endogenous FGF in wound repair. The application of FCFß increased the global synthesis of the collagen, in higher intensity the type I than type III collagen. This finding must have contributed strongly to the maturation of collagen corroborated by several studies 2, 3, 4, 7, 12, 14, 15, 36, 37, 38, 39, 40, 41 .
Conclusion
The topical treatment with FCFb influenced the evolution of infected and clean skin wounds of rats. The healing time was accelerated, the inflammatory reaction was favorable as well as the deposition of I and III collagen. The antibody anti-FCFb neutralized the FCFb effects.
